Bisphosphonate-Associated Orbital Inflammation | Synapse
February 14, 2026
Bisphosphonate-Associated Orbital Inflammation
Key Points
To report a case of preseptal and orbital inflammation linked to bisphosphonate treatment.
Case report detailing the patient's history and treatment
Administered intravenous zoledronate for osteoporosis
Monitored symptoms and inflammation post-treatment
Diagnosis of preseptal and orbital inflammation confirmed
The inflammation arose after administration of zoledronate
Symptoms occurred in a 64-year-old woman following treatment
Abstract
This case report describes a diagnosis of preseptal and orbital inflammation after intravenous infusion of the bisphosphonate zoledronate for osteoporosis in a woman aged 64 years.